News
Tozorakimab, an anti-IL-33 antibody, improves lung function and may reduce exacerbations in high-risk COPD patients, early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback